DEF: OptimizeRx Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals

OptimizeRx Corporation will hold its annual stockholders meeting virtually on June 11, 2025, to vote on director elections, executive compensation, and auditor ratification.

Summary

• OptimizeRx Corporation will hold its 2025 Annual Meeting of Stockholders on Wednesday, June 11, 2025, at 10:00 a.m. EDT, as a virtual meeting via live audio webcast.
• Stockholders of record as of April 29, 2025, are eligible to vote.
• The meeting will address the election of five director nominees, an advisory vote on executive compensation, and the ratification of UHY LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends voting 'FOR' each director nominee, 'FOR' the advisory vote on executive compensation, and 'FOR' the ratification of UHY LLP.
• Proxy materials, including the notice of the annual meeting, proxy statement, and the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, are being distributed starting on or about April 30, 2025.
• Stockholders can submit questions in advance of the meeting until 11:59 p.m. EDT on June 10, 2025, via www.proxyvote.com.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment due to the routine nature of the corporate governance processes being followed.

Positives

• The company is providing stockholders with a virtual meeting option for increased accessibility.
• The Board is actively seeking stockholder input through advance question submission.
• The company is adhering to SEC regulations by providing an advisory vote on executive compensation.
• The company is seeking stockholder ratification of its independent auditor, demonstrating good corporate governance practices.

Risks

• The advisory vote on executive compensation is non-binding, meaning the company is not obligated to act on the outcome.
• The virtual meeting format may present technical difficulties for some stockholders.
• The proxy statement includes forward-looking statements that are subject to risks and uncertainties, which could affect actual results.

Future Outlook

The company is focused on long-term value creation and aligning its goals with its responsibilities as a corporate citizen.

Industry Context

This announcement is a routine part of corporate governance, ensuring stockholders have the opportunity to participate in key decisions regarding the company's direction and leadership.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• Employees are indirectly affected by decisions regarding executive compensation and company performance.
• Customers and suppliers may be indirectly affected by the overall governance and strategic direction of the company.

Next Steps

• Stockholders are encouraged to review the proxy materials and vote their shares.
• The company will hold the Annual Meeting on June 11, 2025, and announce the voting results.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, Auditor, OptimizeRx, Voting, Governance